Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,249
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Nashville TN, Columbus OH, Chicago IL, Cleveland OH,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
Complications Related To Activity After Pediatric Both Bone Fractures: Exploring the Effects of Activity on Fracture Displacement
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Nashville TN, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Location: Nashville TN, Atlanta GA, St Louis MO, Charlotte NC,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 0+
Code: NCT03394365
Phase3, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Nashville TN, Atlanta GA, Shiloh IL, St Louis MO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase3, Recruiting
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
for
Relapsed or Refractory Large B-cell Lymphoma
Location: Nashville TN, Newnan GA, St Louis MO, Charlotte NC,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT07479797
Phase3, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Nashville TN, Knoxville TN, Birmingham AL, Atlanta GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer